Neurogene (NGNE) Institutional Ownership $19.69 -0.33 (-1.65%) Closing price 04:00 PM EasternExtended Trading$19.72 +0.02 (+0.13%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Neurogene (NASDAQ:NGNE)CurrentInstitutional OwnershipPercentage52.37%Number ofInstitutional Buyers(last 12 months)52TotalInstitutional Inflows(last 12 months)$141.49MNumber ofInstitutional Sellers(last 12 months)18TotalInstitutional Outflows(last 12 months)$26.36M Get NGNE Insider Trade Alerts Want to know when executives and insiders are buying or selling Neurogene stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data NGNE Institutional Buying and Selling by Quarter Neurogene Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Bank of America Corp DE95,401$1.43M0.0%+81.6%0.669% 8/14/2025 Commodore Capital LP427,866$6.40M0.5%-53.7%2.998% 8/14/2025 Redmile Group LLC1,276,676$19.09M2.0%-2.4%8.945% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,384$80K0.0%-22.9%0.038% 8/14/2025 OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC 34,761$520K0.0%-37.9%0.244% 8/13/2025 Schroder Investment Management Group30,177$451K0.0%N/A0.212% 8/13/2025 Virtus Investment Advisers LLC4,609$69K0.0%-37.3%0.032% 8/12/2025 JPMorgan Chase & Co.6,335$95K0.0%-92.7%0.044% 8/8/2025 Geode Capital Management LLC247,775$3.71M0.0%-4.5%1.737% 8/8/2025 PNC Financial Services Group Inc.4,055$61K0.0%+43.6%0.028% Get the Latest News and Ratings for NGNE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neurogene and its competitors with MarketBeat's FREE daily newsletter. 8/1/2025 Jennison Associates LLC167,563$2.51M0.0%+55.0%1.175% 7/31/2025 AlphaQuest LLC5,119$77K0.0%-22.5%0.036% 7/24/2025 Blair William & Co. IL133,236$1.99M0.0%-11.9%0.934% 6/27/2025 Goldman Sachs Group Inc.21,176$248K0.0%-44.4%0.148% 5/16/2025 Goldman Sachs Group Inc.21,176$248K0.0%-44.4%0.148% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.6,983$82K0.0%+17.9%0.049% 5/16/2025 ADAR1 Capital Management LLC27,925$327K0.1%N/A0.196% 5/15/2025 Redmile Group LLC1,308,063$15.32M1.4%-0.9%9.172% 5/15/2025 Baker BROS. Advisors LP1,486,200$17.40M0.2%+120.4%10.421% 5/14/2025 Corebridge Financial Inc.5,826$68K0.0%+13.8%0.041% 5/14/2025 Walleye Capital LLC94,083$1.10M0.0%+25.7%0.660% 5/14/2025 AlphaQuest LLC6,609$77K0.0%N/A0.046% 5/14/2025 EntryPoint Capital LLC12,666$148K0.1%N/A0.089% 5/14/2025 Wellington Management Group LLP34,421$403K0.0%+58.5%0.241% 5/12/2025 Nuveen LLC27,482$322K0.0%N/A0.193% 5/12/2025 Mitsubishi UFJ Asset Management Co. Ltd.11,231$132K0.0%+9.1%0.079% 5/9/2025 Deutsche Bank AG150,862$1.77M0.0%-1.0%1.058% 5/9/2025 Charles Schwab Investment Management Inc.33,969$398K0.0%+12.0%0.238% 5/9/2025 Raiffeisen Bank International AG30,000$351K0.0%+87.5%0.210% 5/9/2025 Blair William & Co. IL151,180$1.77M0.0%+141.3%1.060% 5/5/2025 Jennison Associates LLC108,084$1.27M0.0%+48.9%0.758% 4/29/2025 Bank of New York Mellon Corp24,445$286K0.0%+8.2%0.164% 4/7/2025 GAMMA Investing LLC4,134$48K0.0%+2,985.1%0.028% 3/24/2025 Wellington Management Group LLP21,717$496K0.0%+18.7%0.146% 2/17/2025 Vestal Point Capital LP80,000$1.83M0.1%N/A0.539% 2/17/2025 Squarepoint Ops LLC17,431$398K0.0%+250.0%0.117% 2/17/2025 Two Sigma Investments LP20,629$472K0.0%N/A0.139% 2/17/2025 RTW Investments LP1,350,256$30.87M0.5%+18.9%9.090% 2/17/2025 Raiffeisen Bank International AG16,000$356K0.0%N/A0.108% 2/17/2025 Redmile Group LLC1,319,763$30.17M2.1%+36.9%8.884% Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the September 1st funding windo2/17/2025 OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC32,734$748K0.1%+270.8%0.220% 2/17/2025 Octagon Capital Advisors LP303,000$6.93M1.1%+1,920.0%2.040% 2/17/2025 Deutsche Bank AG152,371$3.48M0.0%-54.4%1.026% 2/17/2025 DAFNA Capital Management LLC51,500$1.18M0.3%+562.4%0.347% 2/17/2025 Deerfield Management Company L.P. Series C448,145$10.25M0.2%N/A3.018% 2/17/2025 Driehaus Capital Management LLC32,765$749K0.0%-67.9%0.221% 2/17/2025 Casdin Capital LLC1,295,361$29.61M2.0%+146.9%8.723% 2/17/2025 Baker BROS. Advisors LP674,450$15.42M0.2%+47.9%4.542% 2/17/2025 BNP Paribas Financial Markets1,380$32K0.0%-36.4%0.009% 2/17/2025 ArrowMark Colorado Holdings LLC448,601$10.26M0.1%+16.1%3.021% 2/14/2025 Samsara BioCapital LLC1,717,127$39.25M5.3%+35.4%11.563% 2/14/2025 Schonfeld Strategic Advisors LLC9,189$210K0.0%-71.9%0.062% 2/14/2025 Northern Trust Corp100,566$2.30M0.0%+6.2%0.677% 2/14/2025 The Manufacturers Life Insurance Company14,079$322K0.0%N/A0.095% 2/14/2025 Virtus ETF Advisers LLC3,183$73K0.0%+45.1%0.021% 2/14/2025 Price T Rowe Associates Inc. MD123,291$2.82M0.0%N/A0.830% 2/14/2025 Rock Springs Capital Management LP95,407$2.18M0.1%N/A0.642% 2/13/2025 Walleye Capital LLC74,836$1.71M0.0%+68.2%0.504% 2/13/2025 XTX Topco Ltd15,256$349K0.0%N/A0.103% 2/13/2025 Mariner LLC10,475$239K0.0%N/A0.071% 2/13/2025 Barclays PLC17,533$401K0.0%+18.0%0.118% 2/13/2025 Wells Fargo & Company MN5,444$124K0.0%+34.5%0.037% 2/12/2025 Geode Capital Management LLC234,625$5.37M0.0%+6.4%1.580% 2/12/2025 Wellington Management Group LLP21,717$496K0.0%+18.7%0.146% 2/12/2025 Blair William & Co. IL62,640$1.43M0.0%N/A0.422% 2/12/2025 JPMorgan Chase & Co.481,001$11.00M0.0%+10,395.3%3.239% 2/12/2025 Mitsubishi UFJ Asset Management Co. Ltd.10,290$239K0.0%+72.8%0.069% 2/7/2025 PNC Financial Services Group Inc.3,126$71K0.0%N/A0.021% 2/6/2025 M&T Bank Corp14,138$323K0.0%N/A0.095% 1/30/2025 Rhumbline Advisers15,704$359K0.0%+9.2%0.106% 1/24/2025 Jennison Associates LLC72,596$1.66M0.0%-7.7%0.489% 1/24/2025China Universal Asset Management Co. Ltd.3,150$72K0.0%N/A0.021% 11/27/2024 Franklin Resources Inc.7,050$296K0.0%N/A0.047% 11/19/2024 Barclays PLC14,859$623K0.0%+319.4%0.100% 11/16/2024 Geode Capital Management LLC220,599$9.26M0.0%-0.7%1.698% 11/15/2024 Barclays PLC14,859$623K0.0%+319.4%0.114% 11/15/2024 Jane Street Group LLC7,717$324K0.0%N/A0.059% 11/15/2024 Wellington Management Group LLP18,290$767K0.0%N/A0.141% 11/15/2024 State Street Corp246,540$10.35M0.0%+17.5%1.898% 11/15/2024 RTW Investments LP1,135,256$47.64M0.7%+6.0%8.739% 11/15/2024 Redmile Group LLC964,347$40.46M2.4%-4.9%7.424% 11/15/2024 Janus Henderson Group PLC709,469$29.78M0.0%-15.0%5.462% 11/14/2024 Walleye Capital LLC44,500$1.87M0.0%-51.9%0.343% 11/14/2024 MetLife Investment Management LLC6,054$254K0.0%N/A0.047% 11/13/2024 BNP Paribas Financial Markets2,170$91K0.0%+192.8%0.017% 11/13/2024 FMR LLC731,801$30.71M0.0%+912.4%5.634% 11/12/2024 Charles Schwab Investment Management Inc.30,317$1.27M0.0%+2.5%0.233% 11/8/2024 Jennison Associates LLC78,650$3.30M0.0%N/A0.605% 11/7/2024 Quest Partners LLC1,279$54K0.0%-16.0%0.010% 10/3/2024 SG Americas Securities LLC3,576$150K0.0%N/A0.028% INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (Ad)Right now, we’re witnessing a monumental shift in the world.Our No. 1 AI Pick is currently trading for pennies on the dollar compared to Nividia.8/16/2024 Driehaus Capital Management LLC102,187$3.72M0.0%+123.8%0.787% 8/14/2024 Marshall Wace LLP41,447$1.51M0.0%+37.2%0.319% 8/14/2024 Integral Health Asset Management LLC70,000$2.55M0.2%N/A0.539% 8/14/2024 Avoro Capital Advisors LLC22,029$802K0.0%N/A0.170% 8/9/2024 Renaissance Technologies LLC52,807$1.92M0.0%-10.0%0.407% 8/6/2024 Quest Partners LLC1,523$55K0.0%N/A0.012% 8/1/2024 Rhumbline Advisers13,489$491K0.0%N/A0.104% 7/26/2024 Bank of New York Mellon Corp30,428$1.11M0.0%N/A0.234% 5/16/2024 Janus Henderson Group PLC813,353$41.37M0.0%-3.4%6.266% 5/16/2024 Redmile Group LLC935,252$47.60M1.7%-1.2%7.205% (Data available from 1/1/2016 forward) NGNE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NGNE shares? During the previous two years, 69 institutional investors and hedge funds held shares of Neurogene. The most heavily invested institutionals were Samsara BioCapital LLC ($39.25M), RTW Investments LP ($30.87M), FMR LLC ($30.71M), Janus Henderson Group PLC ($29.78M), Casdin Capital LLC ($29.61M), Vanguard Group Inc. ($25.83M), and Great Point Partners LLC ($19.27M).Learn more on Neurogene's institutional investors. What percentage of Neurogene's stock is owned by institutional investors? 52.37% of Neurogene's stock is owned by institutional investors. Learn more on NGNE's institutional investor holdings. Which institutional investors have been buying Neurogene's stock? Of the 62 institutional investors that purchased Neurogene's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Baker BROS. Advisors LP ($1.03M), Great Point Partners LLC ($994.23K), Casdin Capital LLC ($770.75K), FMR LLC ($659.52K), JPMorgan Chase & Co. ($476.42K), Avidity Partners Management LP ($466.24K), and Vanguard Group Inc. ($457.06K). How much institutional buying is happening at Neurogene? Institutional investors have bought a total of 5,999,099 shares in the last 24 months. This purchase volume represents approximately $141.49M in transactions. Which of Neurogene's major shareholders have been selling company stock? Of the 18 institutional investors that sold Neurogene's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Commodore Capital LP ($497.13K), Deutsche Bank AG ($183.51K), Janus Henderson Group PLC ($125.32K), Redmile Group LLC ($92.40K), JPMorgan Chase & Co. ($80.64K), Driehaus Capital Management LLC ($69.42K), and Walleye Capital LLC ($48K). How much institutional selling is happening at Neurogene? Institutional investors have sold a total of 1,218,852 shares in the last 24 months. This volume of shares sold represents approximately $26.36M in transactions. Related Companies PHVS Major Shareholders GPCR Major Shareholders TLRY Major Shareholders RCUS Major Shareholders LENZ Major Shareholders SYRE Major Shareholders UPB Major Shareholders STOK Major Shareholders VERV Major Shareholders PRAX Major Shareholders This page (NASDAQ:NGNE) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurogene Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurogene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access